Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
MEET THE EXPERT ONLINE: Gram-negative pneumonias - Is the pendulum swinging to Stenotrophomonas and Elizabethkingia species?19 November, 2021 -
Increasingly emerging rare bacterial infection in Taiwan – Elizabethkingia spp.12 November, 2021Professor Jiun-Nong Lin Professor School of Medicine, College of Medicine I-Shou University Taiwan Elizabethkingia has been sporadically reported to cause human infections. ... -
Recent trends in the treatment of community-acquired pneumonia: A Japanese perspective12 November, 2021Professor Katsunori Yanagihara Professor and Chairman, Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences; Head, Laboratory Medicine, Nagasaki... -
Localised vancomycin delivery via microneedle arrays reduces methicillin-resistant Staphylococcus aureus growth on skin12 November, 2021Skin and soft-tissue infections (SSTI) are a common type of bacterial infection, making up almost 10% of annual hospitalisations.1 Staphylococcus aureus is the causative agent in most cases of...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Increasingly emerging rare bacterial infection in Taiwan – Elizabethkingia spp. -
Recent trends in the treatment of community-acquired pneumonia: A Japanese perspective -
Community-acquired pneumonia: Updates in local treatment strategy and clinical experience with levofloxacin -
The role of fluoroquinolone in the treatment of infections caused by antimicrobial-resistant pathogens -
Urinary tract infection: Diagnosis and treatment strategies -
What’s New in the Updated Expert Consensus on Diagnosis and Treatment of Adult Bronchiectasis -
Changes in Chinese Healthcare policies: What’s new in antibiotic treatment options -
Antimicrobial resistance in respiratory tract infections: Current trends and strategies -
Klebsiella pneumoniae liver abscess: The impact of fluoroquinolones treatment on hospital length of stay -
Community-acquired pneumonia: Insights into macrolide resistance and a review of levofloxacin use